378 related articles for article (PubMed ID: 7916048)
1. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic feline immunodeficiency virus infection on experimental feline calicivirus-induced disease.
Reubel GH; George JW; Higgins J; Pedersen NC
Vet Microbiol; 1994 Apr; 39(3-4):335-51. PubMed ID: 8042279
[TBL] [Abstract][Full Text] [Related]
3. Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats.
Reubel GH; George JW; Barlough JE; Higgins J; Grant CK; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):95-119. PubMed ID: 1363011
[TBL] [Abstract][Full Text] [Related]
4. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
[TBL] [Abstract][Full Text] [Related]
5. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus.
Rideout BA; Moore PF; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):71-81. PubMed ID: 1363010
[TBL] [Abstract][Full Text] [Related]
6. Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections.
Lin DS; Bowman DD; Jacobson RH
J Clin Microbiol; 1992 Jan; 30(1):17-24. PubMed ID: 1346403
[TBL] [Abstract][Full Text] [Related]
7. Effect of primary phase feline immunodeficiency virus infection on cats with chronic toxoplasmosis.
Lappin MR; Gasper PW; Rose BJ; Powell CC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):121-31. PubMed ID: 1363007
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats.
Lappin MR; George JW; Pedersen NC; Barlough JE; Murphy CJ; Morse LS
J Parasitol; 1996 Oct; 82(5):733-42. PubMed ID: 8885881
[TBL] [Abstract][Full Text] [Related]
9. Altered surface antigen expression on peripheral blood mononuclear cells in cats infected with feline immunodeficiency virus.
Ohno K; Watari T; Goitsuka R; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1992 Jun; 54(3):517-22. PubMed ID: 1322715
[TBL] [Abstract][Full Text] [Related]
10. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
Pedersen NC; North TW; Rigg R; Reading C; Higgins J; Leutenegger C; Henderson GL
Vet Immunol Immunopathol; 2003 Aug; 94(3-4):133-48. PubMed ID: 12909410
[TBL] [Abstract][Full Text] [Related]
11. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.
Yang JS; English RV; Ritchey JW; Davidson MG; Wasmoen T; Levy JK; Gebhard DH; Tompkins MB; Tompkins WA
J Virol; 1996 May; 70(5):3011-7. PubMed ID: 8627777
[TBL] [Abstract][Full Text] [Related]
12. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.
Bishop SA; Williams NA; Gruffydd-Jones TJ; Harbour DA; Stokes CR
AIDS; 1992 Mar; 6(3):287-93. PubMed ID: 1348945
[TBL] [Abstract][Full Text] [Related]
13. Feline immunodeficiency virus (FIV) infection leads to increased incidence of feline odontoclastic resorptive lesions (FORL).
Hofmann-Lehmann R; Berger M; Sigrist B; Schawalder P; Lutz H
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):299-308. PubMed ID: 9839881
[TBL] [Abstract][Full Text] [Related]
14. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
15. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis.
Davidson MG; Rottman JB; English RV; Lappin MR; Tompkins MB
Am J Pathol; 1993 Nov; 143(5):1486-97. PubMed ID: 8238262
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus.
Novotney C; English RV; Housman J; Davidson MG; Nasisse MP; Jeng CR; Davis WC; Tompkins MB
AIDS; 1990 Dec; 4(12):1213-8. PubMed ID: 1982410
[TBL] [Abstract][Full Text] [Related]
17. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
[TBL] [Abstract][Full Text] [Related]
18. Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats.
Dandekar S; Beebe AM; Barlough J; Phillips T; Elder J; Torten M; Pedersen N
J Virol; 1992 Jul; 66(7):4040-9. PubMed ID: 1318395
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha responses are depressed and interleukin-6 responses unaltered in feline immunodeficiency virus infected cats.
Ma J; Kennedy-Stoskopf S; Sellon R; Tonkonogy S; Hawkins EC; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 1995 May; 46(1-2):35-50. PubMed ID: 7618260
[TBL] [Abstract][Full Text] [Related]
20. The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression.
Holznagel E; Hofmann-Lehmann R; Leutenegger CM; Allenspach K; Huettner S; Forster U; Niederer E; Joller H; Willett BJ; Hummel U; Rossi GL; Schüpbach J; Lutz H
J Virol; 1998 Nov; 72(11):9025-33. PubMed ID: 9765447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
